Book chapter · 2022

Drug discovery for cancer therapy with special reference to inhibitors of protein kinase pathway

Chirasmita Nayak, Sanjeev Kumar Singh

Elsevier eBooks, 71–96 · Published 1 January 2022 · DOI 10.1016/b978-0-323-91287-7.00024-7

View at the publisherCite this paper

In brief

“Drug discovery for cancer therapy with special reference to inhibitors of protein kinase pathway” is a 2022 book chapter by Chirasmita Nayak and Sanjeev Kumar Singh, published in Elsevier eBooks. OpenAlex counts 6 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
6
Most cited in
2024 (4)
Field-weighted impact
2.23
References
99
Authors
2

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Nayak, C., & Singh, S. K. (2022). Drug discovery for cancer therapy with special reference to inhibitors of protein kinase pathway. Elsevier eBooks, 71–96. https://doi.org/10.1016/b978-0-323-91287-7.00024-7

MLA 9

Nayak, Chirasmita, and Sanjeev Kumar Singh. “Drug discovery for cancer therapy with special reference to inhibitors of protein kinase pathway.” Elsevier eBooks, 2022, pp. 71–96. https://doi.org/10.1016/b978-0-323-91287-7.00024-7.

Chicago

Nayak, Chirasmita and Sanjeev Kumar Singh. 2022. “Drug discovery for cancer therapy with special reference to inhibitors of protein kinase pathway.” Elsevier eBooks: 71–96. https://doi.org/10.1016/b978-0-323-91287-7.00024-7.

Harvard

Nayak, C. and Singh, S. K. (2022) ‘Drug discovery for cancer therapy with special reference to inhibitors of protein kinase pathway’, Elsevier eBooks, pp. 71–96. doi:10.1016/b978-0-323-91287-7.00024-7.

IEEE

C. Nayak and S. K. Singh, “Drug discovery for cancer therapy with special reference to inhibitors of protein kinase pathway,” Elsevier eBooks, pp. 71–96, 2022, doi: 10.1016/b978-0-323-91287-7.00024-7.

BibTeX

@incollection{nayak2022drug,
  title     = {{Drug discovery for cancer therapy with special reference to inhibitors of protein kinase pathway}},
  author    = {Nayak, Chirasmita and Singh, Sanjeev Kumar},
  booktitle = {Elsevier eBooks},
  publisher = {Elsevier BV},
  year      = {2022},
  pages     = {71--96},
  doi       = {10.1016/b978-0-323-91287-7.00024-7},
  url       = {https://doi.org/10.1016/b978-0-323-91287-7.00024-7}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202311
202444
202511

Its field-weighted citation impact is 2.23: it has been cited 2.23 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy

  • protein kinases
  • kinase inhibitors
  • cancer therapy
  • drug discovery
  • kinase classification

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Nayak, C., & Singh, S. K. (2022). Drug discovery for cancer therapy with special reference to inhibitors of protein kinase pathway. Elsevier eBooks, 71–96. https://doi.org/10.1016/b978-0-323-91287-7.00024-7

How many times has this paper been cited?

6 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Chirasmita Nayak, Sanjeev Kumar Singh.

What is the DOI of this paper?

10.1016/b978-0-323-91287-7.00024-7, permanently at https://doi.org/10.1016/b978-0-323-91287-7.00024-7. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.